When referring to this article, please cite it as Hennessy, M. How Innovation and Risk Management Are Reshaping Modern Drug ...
- Maintenance formulation of small molecule ASC30 demonstrated an observed half-life of 75 days in participants with obesity in the U.S. Phase Ib study. - 75-day observed half-life supports ...
VANCOUVER - InMed Pharmaceuticals Inc. (NASDAQ: INM), a small-cap biotech company with a market capitalization of $2.21 ...
Clinical trials for drug development are notoriously slow and expensive, and only a small fraction of drug candidates end up being approved by the regulatory authorities. The extensive bottlenecks in ...
- The 12-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of the once-monthly subcutaneous (SQ) depot formulation (treatment formulation) of small molecule GLP-1 receptor ...
Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...
(Nanowerk News) Taking medications on time, in the right dose and for the prescribed duration can be challenging for patients, and failure to do so comes with steep costs, causing 10% of ...
Solubility is an essential characteristic for any oral medication, directly governing the drug’s bioavailability and efficacy. However, this requirement is running up against the growing ...
NEW YORK, Dec. 2, 2024 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global Small Molecule Drug Discovery Market Analysis and Forecast by Size, Share, Growth, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback